LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $212.45M |
| Net Income (Most Recent Fiscal Year) | $-18.88M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.76 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 56.32 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -1.32% |
| Net Margin (Trailing 12 Months) | -1.82% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -6.44% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.73 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.66 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 10.58 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.09 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.10 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.53 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.17 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 48.14M |
| Free Float | 39.28M |
| Market Capitalization | $192.54M |
| Average Volume (Last 20 Days) | 1.18M |
| Beta (Past 60 Months) | 1.36 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 18.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 35.52% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |